The RCLD conducts a well-established and highly successful Enrichment Program through our seminar series, annual symposium and meetings of Special Interest Groups (SIG) of our Themes. The Enrichment Program is of great benefit to our senior and junior faculty members and the many postdoctoral fellows and graduate students who work with members as well as the entire University community. Proposed revisions in the enrichment program will enhance the research progress of junior faculty, allowing for more interactions with trainees during biannual poster sessions and strengthen interactions within our SIG programs by offering twice yearly minisymposium/workshops geared to specific areas of research interests. The Enrichment Program has the following Specific Aims: 1) Organize and support a seminar series, which provides an educational forum to expose Center members and their staff to cutting edge science relevant to the themes of the Center; 2) Support an Annual Symposium to facilitate interactions with and feedback from the External Scientific Advisory Board and the constructive review and monitoring of P/F projects; 3) Provide, through the seminar series, a forum for mentoring and enhancement of collaborations through research-in-progress presentations and poster sessions, which provide junior faculty and trainees with feedback and established investigators with an opportunity to discuss roadblocks in the progress of their work and provide critical review of their studies; and 4) Develop a biannual SIG specific minisymposium/workshop to promote collaborations within the SIG by inviting non-USC leaders in the field. In summary, the RCLD Enrichment Program serves a key role to inform members and promote collaborations within the RCLD and to expose the USC research community to ongoing advances in the field of digestive diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK048522-25
Application #
9882998
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753
Zhang, Chunying; Niu, Chao; Yang, Kevin et al. (2018) Human esophageal myofibroblast secretion of bone morphogenetic proteins and GREMLIN1 and paracrine regulation of squamous epithelial growth. Sci Rep 8:12354
Tsai, Yuan-Li; Ha, Dat P; Zhao, He et al. (2018) Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-? signaling. Proc Natl Acad Sci U S A 115:E4245-E4254
Chen, Jingwen; Lam, Albert T; Zhang, Yong (2018) A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases. Anal Biochem 543:132-139
Chang, Huiyi H; Yeh, Jih-Chao; Ichiyama, Ronaldo M et al. (2018) Mapping and neuromodulation of lower urinary tract function using spinal cord stimulation in female rats. Exp Neurol 305:26-32
Chen, Chien-Yu; Chen, Jingyu; He, Lina et al. (2018) PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne) 9:338
Nakamura, Brooke N; Glazier, Alison; Kattah, Michael G et al. (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13:e0195893
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Wu, Raymond; Murali, Ramachandran; Kabe, Yasuaki et al. (2018) Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. Hepatology 68:1726-1740
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2018) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol 141:1147-1151.e8

Showing the most recent 10 out of 449 publications